Delivery Order SPE2DB24D2205-SPE2DB25FEFJX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count) valued at $6,601.92. This non-competitive, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $18,087.66. This firm fixed price, non-set-aside delivery order was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a direct pharmaceutical procurement to support...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $50,513.86 on September 19, 2025, for the supply of Concerta ER 54 mg tablets (100 count). The contract is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through competitive procurement with no set-aside designation. This delivery...
- The Defense Logistics Agency (DLA) awarded a $9,956.84 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Concerta ER 54 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility and an ultimate completion date of July 11, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,413.32 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,287,331 units of the pharmaceutical product Concerta ER 36 mg tablets. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) under a firm fixed price contract valued at $4,943.14, with an ultimate completion date of September 8, 2025. This non-set-aside award was competitively procured and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,313.52 to AmerisourceBergen Drug Corp for the supply of Concerta ER 54 mg tablets (100-count units) under a firm fixed price contract type. The award was made on May 12, 2025, with an ultimate completion date of May 13, 2025, and represents a non-set-aside competitive award. Performance will take place at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,475.54 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Concerta ER 18 mg tablets (100-count package). This is a firm fixed-price, non-set-aside contract with a completion date of September 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,899.43 to AmerisourceBergen Drug Corp for the supply of Concerta ER 18 mg tablets (100 count) on August 11, 2025, with ultimate completion by August 12, 2025. This firm fixed price delivery order carries no set-aside designation and was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100-count) with a ceiling value of $1,801.16. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 9, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's primary hub for pharmaceutical...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFJXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,690.75 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100 count) under a firm fixed price contract. This non-set-aside award was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pharmaceutical procurement supporting federal medical supply needs, consistent with DLA's role in supplying the military health system and other government healthcare programs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical products to support military and veteran healthcare systems. The company's competitively awarded contracts with DLA demonstrate its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains on an expedited basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.7k | 7/25/25 |